Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 17CNS 3Myeloid 2Genitourinary 2Gastrointestinal 2Breast 2Thoracic 1Lymphoid 1Head & Neck 1Gynecologic 1Dermatologic 1

Conditions

Myelodysplastic Syndromes 33Leukemia, Myeloid, Acute 25Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Hodgkin Disease 19Leukemia, Myelogenous, Chronic, BCR-ABL Positive 17Lymphoma, Non-Hodgkin 16Myeloproliferative Disorders 15Leukemia, Lymphocytic, Chronic, B-Cell 15Multiple Myeloma 14Graft vs Host Disease 14Leukemia 13Primary Myelofibrosis 11Lymphoma, Mantle-Cell 11Lymphoma, Large B-Cell, Diffuse 10Lymphoma, Follicular 10Leukemia, Myelomonocytic, Chronic 10Leukemia, Myeloid, Accelerated Phase 10Lymphoma, B-Cell, Marginal Zone 9Lymphoma 9Leukemia, Myeloid, Chronic-Phase 9Burkitt Lymphoma 9Blast Crisis 9Waldenstrom Macroglobulinemia 7Myelodysplastic-Myeloproliferative Diseases 7Lymphoma, Large-Cell, Immunoblastic 7Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 7Neoplasms, Plasma Cell 6Lymphoma, T-Cell, Cutaneous 6Lymphoma, Large-Cell, Anaplastic 6Leukemia, Prolymphocytic 6

Interventions

X-Rays 5Phantoms, Imaging 5Magnetic Resonance Spectroscopy 5Specimen Handling 4Nuclear Medicine Department, Hospital 4Cyclophosphamide 3Biopsy 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2ensartinib 2Vemurafenib 2Sirolimus 2Radiotherapy 2Psychiatric Rehabilitation 2LY3023414 2Filgrastim 2Etoposide 2Busulfan 2temsirolimus 1selinexor 1sargramostim 1ripretinib 1ixabepilone 1fludarabine phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sarcoma × Sirolimus × Myeloid × Clear all
NCT01552434 2026-05-15

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

M.D. Anderson Cancer Center

Phase 1 Terminated
154 enrolled
BreastCNSGenitourinaryHead & NeckLymphoidMyeloidSarcoma

Breast Neoplasms, Carcinoma, Transitional Cell, Endocrine Gland Neoplasms, Castleman Disease, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Pharyngeal Neoplasms, Recurrence, Sarcoma, Soft Tissue Neoplasms, Thyroid Neoplasms, Urologic Neoplasms, Neurofibromatosis 2, Lymphangioleiomyomatosis, Neoplasms, Mesothelial, Erdheim-Chester Disease

NCT02574728 2026-03-02

AflacST1502

Emory University

Phase 2 Active not recruiting
46 enrolled
CNSMyeloidSarcoma

Brain Neoplasms, Carcinoma, Ependymoma, Histiocytosis, Langerhans-Cell, Medulloblastoma, Neoplasms, Neoplasms, Germ Cell and Embryonal, Neuroblastoma, Pinealoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡